In addition, the term mixed connective tissue disease (MCTD) is used to define a combination of clinical manifestations of SLE, cutaneous systemic sclerosis and polymyositis/dermatomyositis, in the presence of anti-U1-RNP antibodies. This evidence concerns the gene RNPC3 and mixed connective tissue disease.